Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease
Brain · 2024
DOI: 10.1093/brain/awae061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Verena Pesch und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Biologische Informationsprozesse, Strukturbiochemie (IBI-7), Forschungszentrum Jülich, 52425 Jülich, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Mice, Transgenic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, The Michael J. Fox Foundation for Parkinson’s Research, Weston Brain Institute.
Abstract (Originalsprache)
The pathological misfolding and aggregation of soluble α-synuclein into toxic oligomers and insoluble amyloid fibrils causes Parkinson’s disease, a progressive age-related neurodegenerative disease for which there is no cure. HET-s is a soluble fungal protein that can form assembled amyloid fibrils in its prion state. We engineered HET-s(218–298) to form four different fibrillar vaccine candidates, each displaying a specific conformational epitope present on the surface of α-synuclein fibrils. Vaccination with these four vaccine candidates prolonged the survival of immunized TgM83+/− mice challenged with α-synuclein fibrils by 8% when injected into the brain to model brain-first Parkinson’s disease or by 21% and 22% when injected into the peritoneum or gut wall, respectively, to model body-first Parkinson’s disease. Antibodies from fully immunized mice recognized α-synuclein fibrils and brain homogenates from patients with Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. Conformation-specific vaccines that mimic epitopes present only on the surface of pathological fibrils but not on soluble monomers, hold great promise for protection against Parkinson’s disease, related synucleinopathies and other amyloidogenic protein misfolding disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Biologische Informationsprozesse, Strukturbiochemie (IBI-7), Forschungszentrum Jülich, 52425 Jülich, Germany.
- Department of Biochemistry and Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB T6G 2M8, Canada.
- Department of Cell Biology and Anatomy, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Physics Department, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.
- Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2M8, Canada.
- Institut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.
ORCID-Profile: Holger Wille, Gültekin Tamgüney
Förderung
- NIGMS NIH HHS
- The Michael J. Fox Foundation for Parkinson’s Research
- Weston Brain Institute
Zitieren
APA
Pesch, V., Flores-Fernandez, J. M., Reithofer, S., Ma, L., Özdüzenciler, P., Busch, Y., Sriraman, A., Wang, Y., Amidian, S., Kroepel, C. V. M., Müller, L., Lien, Y., Rudtke, O., Frieg, B., Schröder, G. F., Wille, H., & Tamgüney, G. (2024). Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease. Brain. https://doi.org/10.1093/brain/awae061
Vancouver
Pesch V, Flores-Fernandez JM, Reithofer S, Ma L, Özdüzenciler P, Busch Y, et al. Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease. Brain. 2024. doi:10.1093/brain/awae061
BibTeX
@article{Pesch2024,
author = {Pesch, Verena and Flores-Fernandez, José Miguel and Reithofer, Sara and Ma, Liang and Özdüzenciler, Pelin and Busch, Yannick and Sriraman, Aishwarya and Wang, YongLiang and Amidian, Sara and Kroepel, Chiara V M and Müller, Laura and Lien, Yi and Rudtke, Olivia and Frieg, Benedikt and Schröder, Gunnar F and Wille, Holger and Tamgüney, Gültekin},
title = {Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae061}
}
EUVIMED